Brighton-based FlexDex Surgical Inc. has closed on a funding round of $13 million, which was led by New Brunswick, N.J.-based Johnson & Johnson Innovation LLC, the investment arm of the pharmaceutical giant, and Almeda Ventures, an Israel firm based in Tel Aviv.
The round was joined by a…
DBusiness Magazine
Biotech Boom
As Ann Arbor begins to fulfill its potential as a dynamic biotech hub, the broader impact could be profound.
Cameron McCausland // Photograph by Austin Phillips
There are few circumstances that better illustrate the importance of biomedical innovation than what’s happening in society right now. Across the country and around the world, the potential for new ideas, new medicines, and new therapeutic options to, quite literally, change lives has perhaps never been more apparent.
Biotech breakthroughs require not only cutting-edge scientific and medical resources and expertise, but the necessary entrepreneurial energy to create and sustain them. It’s a rare and valuable combination.